Validation of Argo (Automatic record generator for Onco-Hematology), a New App Supporting the Automatic Conversion of Paper-Based Pathology Reports in Standardized Ecrfs
Gian Maria Zaccaria(Politecnico di Torino), Sabino Ciavarella(Istituto Tumori Bari), Simone Ferrero(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Angela Maria Quinto(Platinum Group Coatings (United States)), Paolo Mondelli(Istituto Tumori Bari), Luigi Alfredo Grieco(Polytechnic University of Bari), Fabio Pavone(Istituto Tumori Bari), Simona Colucci, Riccardo Moia(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Anna Scattone(Istituto Tumori Bari), Grazia Gargano(Istituto Tumori Bari), Vito Angiulli(Istituto Tumori Bari), Benedetta Puccini(Azienda Ospedaliero-Universitaria Careggi), Carla Minoia(Istituto Tumori Bari), Chiara Pagani(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), A Bucci(Istituto Tumori Bari), Francesco Berloco(Polytechnic University of Bari), Attilio Guarini(Istituto Tumori Bari), Valentina Tabanelli(Istituti di Ricovero e Cura a Carattere Scientifico), Giacomo Loseto(Istituto Tumori Bari), Alice Di Rocco(Policlinico Umberto I), Angelo Famà(Azienda Sanitaria Unità Locale di Reggio Emilia), Francesca Maria Quaglia(University of Verona), Anita Susanna Pappagallo(Istituto Tumori Bari), G Carella(Istituto Tumori Bari), Felice Clemente(Istituto Tumori Bari), Tetiana Skrypets(University of Modena and Reggio Emilia), Giacomo Volpe(Chinese Academy of Sciences), Bernardo Rossini(Istituto Tumori Bari), Maria Carmela Vegliante(Aristotle University of Thessaloniki)
Cited by 0
Related Papers
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
|The Lancet Haematology|2020|553
Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders
|Leukemia|2013|305
Major Tumor Shrinking and Persistent Molecular Remissions After Consolidation With Bortezomib, Thalidomide, and Dexamethasone in Patients With Autografted Myeloma
|Journal of Clinical Oncology|2010|268